「nov」の検索結果
23件：1～5件目を表示
-
harmaceutical Co., Ltd. Senju has Applied for Manufacturing and Marketing Approval in Japan for the novel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117.pdf -
Research and Development System | Research & Development | SENJU Pharmaceutica
ional frameworks and preconceptions. Our mission is to look toward the future and swiftly deliver innovative drugs that are truly needed by patients suffering from diseases. Hideki Tokushige, Executiv...
http://www.senju.co.jp/english/rd/about/ -
harmaceutical Co., Ltd. Senju has successfully completed Phase III clinical trials in Japan for the novel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716_0.pdf -
harmaceutical Co., Ltd. Senju has Applied for Manufacturing and Marketing Approval in Japan for the novel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan...
https://www.senju.co.jp/system/files/content_news/2025-01/ENG_20250117_0.pdf -
harmaceutical Co., Ltd. Senju has successfully completed Phase III clinical trials in Japan for the novel Dry Eye Disease treatment, SJP-0132 Senju Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan...
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716.pdf